Literature DB >> 9226308

Neuropsychological function in adults after high dose fractionated radiation therapy of skull base tumors.

G Glosser1, P McManus, J Munzenrider, M Austin-Seymour, B Fullerton, J Adams, M M Urie.   

Abstract

PURPOSE: To evaluate the long term effects of high dose fractionated radiation therapy on brain functioning prospectively in adults without primary brain tumors. METHODS AND MATERIALS: Seventeen patients with histologically confirmed chordomas and low grade chondrosarcomas of the skull base were evaluated with neuropsychological measures of intelligence, language, memory, attention, motor function and mood following surgical resection/biopsy of the tumor prior to irradiation, and then at about 6 months, 2 years and 4 years following completion of treatment. None received chemotherapy.
RESULTS: In the patients without tumor recurrence or radiation necrosis, there were no indications of adverse effects on cognitive functioning in the post-acute through the late stages after brain irradiation. Even in patients who received doses of radiation up to 66 Cobalt Gy equivalent through nondiseased (temporal lobe) brain tissue, memory and cognitive functioning remained stable for up to 5 years after treatment. A mild decline in psychomotor speed was seen in more than half of the patients, and motor slowing was related to higher radiation doses in midline and temporal lobe brain structures.
CONCLUSION: Results suggest that in adults, tolerance for focused radiation is relatively high in cortical brain structures.

Entities:  

Mesh:

Year:  1997        PMID: 9226308     DOI: 10.1016/s0360-3016(97)00099-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Neurocognitive long-term impact of two-field conventional radiotherapy in adult patients with operated pituitary adenomas.

Authors:  Beatriz Lecumberri; Javier Estrada; José García-Uría; Isabel Millán; Luis Felipe Pallardo; Luis Caballero; Tomás Lucas
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

Review 2.  Proton therapy for tumors of the skull base.

Authors:  J E Munzenrider; N J Liebsch
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

3.  Allocentric visuospatial processing in patients with cerebral gliomas: a neurocognitive assessment.

Authors:  V Jagaroo; M P Rogers; P M Black
Journal:  J Neurooncol       Date:  2000-09       Impact factor: 4.130

Review 4.  The evolving role of stereotactic radiosurgery for patients with skull base tumors.

Authors:  Bruce E Pollock; Robert L Foote
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

5.  Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery.

Authors:  Edward A Neuwelt; Paul E Guastadisegni; Péter Várallyay; Nancy D Doolittle
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

6.  Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module.

Authors:  Chase C Hansen; Joshua B Smith; Abdallah S R Mohamed; Collin F Mulcahy; Jeffrey S Wefel; Katherine A Hutcheson; Kelsey Chrane; Jack Phan; Steven J Frank; Adam S Garden; Blaine D Smith; Hillary Eichelberger; Carthal Anderson; Colton McCoy; Marina Horiates; Conner Patrick; Sarah Floris; Chloe French; Beth M Beadle; William H Morrison; Shirley Y Su; Carol M Lewis; Michael E Kupferman; Jason M Johnson; Heath D Skinner; Stephen Y Lai; Ehab Y Hanna; David I Rosenthal; Clifton D Fuller; G Brandon Gunn
Journal:  Head Neck       Date:  2017-08-01       Impact factor: 3.147

7.  Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma.

Authors:  Deborah Y Park; Martin C Tom; Wei Wei; Surabhi Tewari; Manmeet S Ahluwalia; Jennifer S Yu; Samuel T Chao; John H Suh; David Peereboom; Glen H J Stevens; Gene H Barnett; Lilyana Angelov; Alireza M Mohammadi; Thomas Hogan; Courtney Kissel; Brittany Lapin; Isabel Schuermeyer; Michael W Parsons; Richard Naugle; Erin S Murphy
Journal:  J Neurooncol       Date:  2022-01-22       Impact factor: 4.130

8.  Baseline Cognition Assessment Among Patients With Oropharyngeal Cancer Using PROMIS and NIH Toolbox.

Authors:  Parul Sinha; Alex W K Wong; Dorina Kallogjeri; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-11-01       Impact factor: 6.223

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.